89bio, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2019 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
89bio, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2019 to Q4 2024.
- 89bio, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $257K, a 93.4% decline year-over-year.
- 89bio, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $692K, a 82.1% decline year-over-year.
- 89bio, Inc. annual Income Tax Expense (Benefit) for 2024 was $692K, a 82.1% decline from 2023.
- 89bio, Inc. annual Income Tax Expense (Benefit) for 2023 was $3.87M, a 20253% increase from 2022.
- 89bio, Inc. annual Income Tax Expense (Benefit) for 2022 was $19K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)